North American Neuromodulation Society


NANS strives to continually be engaged in advocacy activities that help promote the field of Neuromodulation. Through our Advocacy Committee and partner organizations, NANS reviews and works on programs and projects related to promoting the field of Neuromodulation. In addition, NANS collaborates with key stakeholders to ensure that patients have satisfactory access to Neuromodulation therapies as a treatment option and that the therapy is used effectively and appropriately. The group also maintains liaison with other key stakeholders, including: industry, government institutions and other interested/related parties to advocate for Neuromodulation as a treatment modality.

The NANS Advocacy and Policy Committee has worked tirelessly through various channels, including our association with the Multi-Society Pain Working Group, the AMA Specialty Section Council and our members’ own initiatives, to keep our members informed of activities and potential legislation that may impact the field of neuromodulation.

Please look for regular updates from the Advocacy and Policy Committee in the NANS Newsletter as well as via e-mail.

NEW!  The NANS Advocacy and Policy Committee is pleased to provide NANS members with an update on some recent activities that have yielded favorable results in efforts to provide coverage for neuromodulation procedures. Effective March 2022, United Healthcare will expand indications for implanted electrical spinal cord stimulators. This change comes from NANS and 11 other medical society members of the Multisociety Pain Workgroup (MPW). They submitted a comment letter to UHC urging the insurer to revise their policy.

The expanded spinal cord stimulator coverage indications will include complex regional pain syndrome (CRPS), diabetic neuropathy, and failed back surgery syndrome. The policy also outlines changes to include coverage of dorsal root ganglion stimulation for treating refractory CRPS I and CRPS II. Read the full policy here.


NANS has also started a PR effort both independently and in collaboration with other specialty societies. Together, we are working on publicizing news articles and events that are taking place within the field of Neuromodulation. Currently, NANS is working on a PR pilot program in the state of California that consists of five test markets focusing on alternatives to opioids. 

PR plays a significant role in our advocacy efforts on behalf of patients and practitioners alike. NANS is developing an expanded page featuring news articles and other features where Neuromodulation is the primary focus. NANS encourages its members to submit articles of interest as well as any success stories from patients who have benefited from this therapy. Please submit all materials to NANS at

To learn more about how you can advocate for Neuromodulation as well as contribute to our PR efforts, please view the video posted here.

The video was produced in collaboration with the American Society of Interventional Pain Physicians (ASIPP).


WIKISTIM is a searchable database being populated with data published in the field of neuromodulation. The goals of WIKISTIM are to improve patient care and the quality of research reports, foster communication, reveal research needs, and support the practice of evidence–based medicine.

NANS Events   

  • Jan. 18-21, 2024

    NANS 2024 Annual Meeting #PatientsFirst
    Caesar's Palace
    Las Vegas, NV 

Contains 0 items
Subtotal: $0.00